Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Considerations for Preventing and Addressing Alopecia in Patients With Religious Headwear
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids
Frontline Forum Part 3: Improving Basal Cell Carcinoma Management